The antibody-drug conjugates market is anticipated to surge as several pharma companies across the globe are thoroughly working toward the development and expansion to treat a wide array of
The ELISA market is expected to prosper due to factors such as the increasing prevalence of infectious diseases such as HIV, tuberculosis, malaria, and hepatitis B, among others, growing application
Increase in Research and Development activities for advancements in anti-psychotic drugs, product launches, and approvals has increased the Schizophrenia market. An increase in the development
Currently, much research is ongoing to develop new and effective therapeutic drugs for the treatment of Heart failure. The treatment of HF is dependent on angiotensin-converting enzyme inhibitor
The rise in the incidence of ARDS stimulates the research and development of the drug, as it is likely to provide an appropriate environment for newer products to be profitable. Companies across